Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Health Strategies Group is a premier provider of market access intelligence and strategic consulting services for the life sciences industry. The company specializes in delivering actionable insights regarding payer behavior, reimbursement trends, and commercialization strategies to pharmaceutical and biotech executives. Founded in 1992, it established a reputation for high-quality research and data-driven decision support. In 2018, the company was acquired by EVERSANA, integrating its specialized expertise into a comprehensive global commercial services platform. Its offerings include managed care research, trade and distribution strategy, and patient access solutions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Health Strategies.